PROSTATE IMAGING-REPORTING AND DATA SYSTEM VERSION 2 IN COMBINATION WITH CLINICAL PARAMETERS FOR PROSTATE CANCER DETECTION

被引：0
作者：
Wang, Lei
Luo, Yi
Liu, Tongzu
Deng, Ming
Wakimoto, Hiroaki
Huang, Xing
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP09-10
引用
收藏
页码：E108 / E108
页数：1
相关论文
共 50 条
  • [41] Reply to "Standardizing Biparametric MRI to Simplify and Improve Prostate Imaging Reporting and Data System, Version 2, in Prostate Cancer Management"
    Rosenkrantz, Andrew B.
    Oto, Aytekin
    Turkbey, Baris
    Westphalen, Antonio C.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (04) : W76 - W76
  • [42] Prostate imaging-reporting and data system version 2 has improved biopsy tumor grade accuracy: a single, tertiary institutional experience
    Park, Yong Woo
    Kang, Kyung A.
    Kim, Chan Kyo
    Park, Sung Yoon
    ABDOMINAL RADIOLOGY, 2023, 48 (07) : 2370 - 2378
  • [43] Prostate imaging-reporting and data system version 2 has improved biopsy tumor grade accuracy: a single, tertiary institutional experience
    Yong Woo Park
    Kyung A Kang
    Chan Kyo Kim
    Sung Yoon Park
    Abdominal Radiology, 2023, 48 : 2370 - 2378
  • [44] Prostagram magnetic resonance imaging in a screening population: Prostate Imaging-Reporting and Data System or Likert?
    Mayor, Nikhil
    Eldred-Evans, David
    Tam, Henry
    Sokhi, Heminder
    Padhani, Anwar R.
    Connor, Martin J.
    Price, Derek
    Gammon, Martin
    Klimowska-Nassar, Natalia
    Burak, Paula
    Day, Emily
    Winkler, Mathias
    Fiorentino, Francesca
    Shah, Taimur
    Ahmed, Hashim Uddin
    BJU INTERNATIONAL, 2024, 133 (01) : 112 - 117
  • [45] Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Richard Hoffmann
    Callum Logan
    Michael O’Callaghan
    Kirsten Gormly
    Ken Chan
    Darren Foreman
    International Urology and Nephrology, 2018, 50 : 13 - 19
  • [46] Comparing Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) Category 1 and 2 Groups: Clinical Implication of Negative Multiparametric Magnetic Resonance Imaging
    Kim, Jung Kwon
    Lee, Hak Jong
    Hwang, Sung Il
    Choe, Gheeyoung
    Hong, Sung Kyu
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [47] Do Prostate Imaging-Reporting and Data System (PIRADS) lesions predict holmium laser enucleation of prostate outcomes?
    Tsai, Kyle
    Xu, Perry
    Guo, Jenny
    Dean, Nicholas
    Khondakar, Nabila
    Michael, Jamie
    Neill, Clayton
    Krambeck, Amy
    PROSTATE, 2024, 84 (14) : 1344 - 1351
  • [48] Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann, Richard
    Logan, Callum
    O'Callaghan, Michael
    Gormly, Kirsten
    Chan, Ken
    Foreman, Darren
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (01) : 13 - 19
  • [49] Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer
    Morris, David S.
    Woods, J. Scott
    Edwards, Byard
    Lenz, Lauren
    Logan, Jennifer
    Flake, Darl D.
    Mabey, Brent
    Bishoff, Jay T.
    Cohen, Todd
    Stone, Steven
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (06) : 366.e19 - 366.e28
  • [50] Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
    Mazzone, Elio
    Stabile, Armando
    Pellegrino, Francesco
    Basile, Giuseppe
    Cignoli, Daniele
    Cirulli, Giuseppe Ottone
    Sorce, Gabriele
    Barletta, Francesco
    Scuderi, Simone
    Bravi, Carlo Andrea
    Cucchiara, Vito
    Fossati, Nicola
    Gandaglia, Giorgio
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (05): : 697 - 713
12345